SubmitCancel

Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

P06493

- CDK1_HUMAN

UniProt

P06493 - CDK1_HUMAN

(max 400 entries)x

Your basket is currently empty.

Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)

Protein
Cyclin-dependent kinase 1
Gene
CDK1, CDC2, CDC28A, CDKN1, P34CDC2
Organism
Homo sapiens (Human)
Status
Reviewed - Annotation score: 5 out of 5 - Experimental evidence at protein leveli

Functioni

Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition, and regulates G1 progress and G1-S transition via association with multiple interphase cyclins. Required in higher cells for entry into S-phase and mitosis. Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, LMNA, LMNB, LMNC, LBR, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, UL40/R2, RAB4A, RAP1GAP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1, SIRT2 and RUNX2. CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs. Essential for early stages of embryonic development. During G2 and early mitosis, CDC25A/B/C-mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation. Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis. Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair. Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression. In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons. The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis. NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis. The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis. In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis. This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration.13 Publications

Catalytic activityi

ATP + a protein = ADP + a phosphoprotein.
ATP + [DNA-directed RNA polymerase] = ADP + [DNA-directed RNA polymerase] phosphate.

Enzyme regulationi

Phosphorylation at Thr-14 or Tyr-15 inactivates the enzyme, while phosphorylation at Thr-161 activates it. Activated through a multistep process; binding to cyclin-B is required for relocation of cyclin-kinase complexes to the nucleus, activated by CAK/CDK7-mediated phosphorylation on Thr-161, and CDC25-mediated dephosphorylation of inhibitory phosphorylation on Thr-14 and Tyr-15. Inhibited by flavopiridol and derivatives, pyrimidine derivatives, pyridine derivatives, purine derivatives, staurosporine, paullones, oxoindoles, indazole analogs, indolin-2-ones, pyrazolo[3,4-b]pyridines, imidazo[1,2-a]pyridine (AZ703), thiazolinone analogs(RO-3306), thiazol urea, macrocyclic quinoxalin-2-one, pyrrolo[2,3-a]carbazole, pyrazolo[1,5-a]-1,3,5-triazine, pyrazolo[1,5-a]pyrimidine (Dinaciclib, SCH 727965), 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine (roscovitine), olomoucine, AG-024322, AT-7519, P276-00, R547/Ro-4584820 and SNS-032/BMS-387032. Repressed by the CDK inhibitors CDKN1A/p21 and CDKN1B/p27 during the G1 phase and by CDKN1A/p21 at the G1-S checkpoint upon DNA damage. Transient activation by rapid and transient dephosphorylation at Tyr-15 triggered by TGFB1.2 Publications

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Binding sitei33 – 331ATP By similarity
Active sitei128 – 1281Proton acceptor By similarity

Regions

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Nucleotide bindingi10 – 189ATP By similarity

GO - Molecular functioni

  1. ATP binding Source: UniProtKB-KW
  2. RNA polymerase II carboxy-terminal domain kinase activity Source: UniProtKB
  3. cyclin-dependent protein serine/threonine kinase activity Source: UniProtKB
  4. histone kinase activity Source: Ensembl
  5. protein binding Source: UniProtKB
  6. protein kinase activity Source: ProtInc
  7. protein serine/threonine kinase activity Source: WormBase

GO - Biological processi

  1. DNA repair Source: UniProtKB
  2. DNA replication Source: UniProtKB
  3. Fc-epsilon receptor signaling pathway Source: Reactome
  4. G1/S transition of mitotic cell cycle Source: Reactome
  5. G2/M transition of mitotic cell cycle Source: Reactome
  6. MAPK cascade Source: Reactome
  7. MyD88-dependent toll-like receptor signaling pathway Source: Reactome
  8. MyD88-independent toll-like receptor signaling pathway Source: Reactome
  9. Ras protein signal transduction Source: Reactome
  10. TRIF-dependent toll-like receptor signaling pathway Source: Reactome
  11. activation of MAPK activity Source: Reactome
  12. activation of MAPKK activity Source: Reactome
  13. anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process Source: Reactome
  14. apoptotic process Source: UniProtKB-KW
  15. axon guidance Source: Reactome
  16. cell aging Source: Ensembl
  17. cell migration Source: UniProtKB
  18. cellular response to hydrogen peroxide Source: Ensembl
  19. centrosome cycle Source: UniProtKB
  20. chromosome condensation Source: Ensembl
  21. epidermal growth factor receptor signaling pathway Source: Reactome
  22. epithelial cell differentiation Source: UniProt
  23. fibroblast growth factor receptor signaling pathway Source: Reactome
  24. innate immune response Source: Reactome
  25. insulin receptor signaling pathway Source: Reactome
  26. microtubule cytoskeleton organization Source: UniProtKB
  27. mitotic G2 DNA damage checkpoint Source: Ensembl
  28. mitotic cell cycle Source: Reactome
  29. mitotic nuclear division Source: UniProtKB-KW
  30. mitotic nuclear envelope disassembly Source: Reactome
  31. negative regulation of apoptotic process Source: UniProtKB
  32. neurotrophin TRK receptor signaling pathway Source: Reactome
  33. organ regeneration Source: Ensembl
  34. peptidyl-serine phosphorylation Source: WormBase
  35. positive regulation of DNA replication Source: Ensembl
  36. positive regulation of cardiac muscle cell proliferation Source: Ensembl
  37. positive regulation of gene expression Source: Ensembl
  38. positive regulation of mitotic cell cycle Source: Ensembl
  39. positive regulation of protein import into nucleus, translocation Source: Ensembl
  40. positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle Source: Reactome
  41. pronuclear fusion Source: UniProtKB
  42. protein complex assembly Source: Ensembl
  43. protein localization to kinetochore Source: BHF-UCL
  44. regulation of Schwann cell differentiation Source: UniProtKB
  45. regulation of embryonic development Source: UniProtKB
  46. regulation of transcription involved in G1/S transition of mitotic cell cycle Source: Reactome
  47. regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle Source: Reactome
  48. response to activity Source: Ensembl
  49. response to amine Source: Ensembl
  50. response to axon injury Source: Ensembl
  51. response to cadmium ion Source: Ensembl
  52. response to copper ion Source: Ensembl
  53. response to drug Source: Ensembl
  54. response to ethanol Source: Ensembl
  55. response to organic cyclic compound Source: Ensembl
  56. response to toxic substance Source: Ensembl
  57. small GTPase mediated signal transduction Source: Reactome
  58. stress-activated MAPK cascade Source: Reactome
  59. toll-like receptor 10 signaling pathway Source: Reactome
  60. toll-like receptor 2 signaling pathway Source: Reactome
  61. toll-like receptor 3 signaling pathway Source: Reactome
  62. toll-like receptor 4 signaling pathway Source: Reactome
  63. toll-like receptor 5 signaling pathway Source: Reactome
  64. toll-like receptor 9 signaling pathway Source: Reactome
  65. toll-like receptor TLR1:TLR2 signaling pathway Source: Reactome
  66. toll-like receptor TLR6:TLR2 signaling pathway Source: Reactome
  67. toll-like receptor signaling pathway Source: Reactome
  68. ventricular cardiac muscle cell development Source: Ensembl
Complete GO annotation...

Keywords - Molecular functioni

Kinase, Serine/threonine-protein kinase, Transferase

Keywords - Biological processi

Apoptosis, Cell cycle, Cell division, Mitosis

Keywords - Ligandi

ATP-binding, Nucleotide-binding

Enzyme and pathway databases

BRENDAi2.7.11.22. 2681.
ReactomeiREACT_1100. Golgi Cisternae Pericentriolar Stack Reorganization.
REACT_111214. G0 and Early G1.
REACT_1321. E2F-enabled inhibition of pre-replication complex formation.
REACT_1391. ERK1 activation.
REACT_150182. MASTL Facilitates Mitotic Progression.
REACT_150260. Condensation of Prometaphase Chromosomes.
REACT_150425. Resolution of Sister Chromatid Cohesion.
REACT_15296. Recruitment of mitotic centrosome proteins and complexes.
REACT_15364. Loss of Nlp from mitotic centrosomes.
REACT_15451. Loss of proteins required for interphase microtubule organization from the centrosome.
REACT_15510. Recruitment of NuMA to mitotic centrosomes.
REACT_160122. Activation of NIMA Kinases NEK9, NEK6, NEK7.
REACT_160315. Regulation of PLK1 Activity at G2/M Transition.
REACT_163931. Nuclear Pore Complex (NPC) Disassembly.
REACT_172744. Condensation of Prophase Chromosomes.
REACT_1846. G2/M DNA replication checkpoint.
REACT_1857. Cyclin A/B1 associated events during G2/M transition.
REACT_200828. Depolymerisation of the Nuclear Lamina.
REACT_2101. Cyclin B2 mediated events.
REACT_407. Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
REACT_471. E2F mediated regulation of DNA replication.
REACT_6362. Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes.
REACT_6820. APC/C:Cdc20 mediated degradation of Cyclin B.
REACT_683. G1/S-Specific Transcription.
REACT_6837. Regulation of APC/C activators between G1/S and early anaphase.
REACT_6875. Phosphorylation of Emi1.
REACT_6904. Phosphorylation of the APC/C.
SignaLinkiP06493.

Names & Taxonomyi

Protein namesi
Recommended name:
Cyclin-dependent kinase 1 (EC:2.7.11.22, EC:2.7.11.23)
Short name:
CDK1
Alternative name(s):
Cell division control protein 2 homolog
Cell division protein kinase 1
p34 protein kinase
Gene namesi
Name:CDK1
Synonyms:CDC2, CDC28A, CDKN1, P34CDC2
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640: Chromosome 10

Organism-specific databases

HGNCiHGNC:1722. CDK1.

Subcellular locationi

Nucleus. Cytoplasm. Mitochondrion. Cytoplasmcytoskeletonmicrotubule organizing centercentrosome. Cytoplasmcytoskeletonspindle
Note: Cytoplasmic during the interphase. Colocalizes with SIRT2 on centrosome during prophase and on splindle fibers during metaphase of the mitotic cell cycle. Reversibly translocated from cytoplasm to nucleus when phosphorylated before G2-M transition when associated with cyclin-B1. Accumulates in mitochondria in G2-arrested cells upon DNA-damage.2 Publications

GO - Cellular componenti

  1. centrosome Source: UniProtKB
  2. cytoplasm Source: HPA
  3. cytosol Source: Reactome
  4. extracellular vesicular exosome Source: UniProt
  5. midbody Source: UniProtKB
  6. mitochondrion Source: UniProtKB
  7. mitotic spindle Source: UniProtKB
  8. nucleoplasm Source: Reactome
  9. nucleus Source: HPA
  10. spindle microtubule Source: UniProtKB
Complete GO annotation...

Keywords - Cellular componenti

Cytoplasm, Cytoskeleton, Mitochondrion, Nucleus

Pathology & Biotechi

Mutagenesis

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Mutagenesisi4 – 41Y → D or E: Constitutive polyubiquitination. 2 Publications
Mutagenesisi14 – 152TY → AF: Abnormal cell cycle exhibiting only M-phase without completing either karyokinesis or cytokinesis. 1 Publication

Organism-specific databases

PharmGKBiPA99.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Chaini1 – 297297Cyclin-dependent kinase 1
PRO_0000085724Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Modified residuei1 – 11N-acetylmethionine3 Publications
Modified residuei4 – 41Phosphotyrosine; by PKR1 Publication
Modified residuei6 – 61N6-acetyllysine1 Publication
Modified residuei9 – 91N6-acetyllysine By similarity
Modified residuei14 – 141Phosphothreonine; by PKMYT14 Publications
Modified residuei15 – 151Phosphotyrosine; by PKMYT1, WEE1, WEE2 and PKC/PRKCD5 Publications
Modified residuei19 – 191Phosphotyrosine2 Publications
Modified residuei39 – 391Phosphoserine2 Publications
Modified residuei77 – 771Phosphotyrosine1 Publication
Cross-linki89 – 89Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)1 Publication
Modified residuei161 – 1611Phosphothreonine; by CAK4 Publications
Modified residuei178 – 1781Phosphoserine1 Publication
Modified residuei222 – 2221Phosphothreonine2 Publications
Modified residuei245 – 2451N6-succinyllysine By similarity
Modified residuei248 – 2481Phosphoserine1 Publication

Post-translational modificationi

Phosphorylation at Thr-161 by CAK/CDK7 activates kinase activity. Phosphorylation at Thr-14 and Tyr-15 by PKMYT1 prevents nuclear translocation. Phosphorylation at Tyr-15 by WEE1 and WEE2 inhibits the protein kinase activity and acts as a negative regulator of entry into mitosis (G2 to M transition). Phosphorylation by PKMYT1 and WEE1 takes place during mitosis to keep CDK1-cyclin-B complexes inactive until the end of G2. By the end of G2, PKMYT1 and WEE1 are inactivated, but CDC25A and CDC25B are activated. Dephosphorylation by active CDC25A and CDC25B at Thr-14 and Tyr-15, leads to CDK1 activation at the G2-M transition. Phosphorylation at Tyr-15 by WEE2 during oogenesis is required to maintain meiotic arrest in oocytes during the germinal vesicle (GV) stage, a long period of quiescence at dictyate prophase I, leading to prevent meiotic reentry. Phosphorylation by WEE2 is also required for metaphase II exit during egg activation to ensure exit from meiosis in oocytes and promote pronuclear formation. Phosphorylated at Tyr-4 by PKR/EIF2AK2 upon genotoxic stress. This phosphorylation triggers CDK1 polyubiquitination and subsequent proteolysis, thus leading to G2 arrest. In response to UV irradiation, phosphorylation at Tyr-15 by PRKCD activates the G2/M DNA damage checkpoint.5 Publications
Polyubiquitinated upon genotoxic stress.

Keywords - PTMi

Acetylation, Isopeptide bond, Phosphoprotein, Ubl conjugation

Proteomic databases

MaxQBiP06493.
PaxDbiP06493.
PRIDEiP06493.

2D gel databases

SWISS-2DPAGEP06493.

PTM databases

PhosphoSiteiP06493.

Expressioni

Tissue specificityi

Isoform 2 is found in breast cancer tissues.

Inductioni

Follows a cyclic expression; during interphase, accumulates gradually following G1, S to reach a critical threshold at the end of G2, which promotes self-activation and triggers onset of mitosis. Induced transiently by TGFB1 at an early phase of TGFB1-mediated apoptosis, but later repressed. Triggered by CKS1B during mitotic entry in breast cancer cells. Down-regulated under genotoxic stresses triggered by PKR/EIF2AK2-mediated phosphorylation.3 Publications

Gene expression databases

ArrayExpressiP06493.
BgeeiP06493.
CleanExiHS_CDC2.
GenevestigatoriP06493.

Organism-specific databases

HPAiCAB003799.
HPA003387.

Interactioni

Subunit structurei

Forms a stable but non-covalent complex with a regulatory subunit and with a cyclin. Interacts with cyclins-B (CCNB1, CCNB2 and CCNB3) to form a serine/threonine kinase holoenzyme complex also known as maturation promoting factor (MPF). The cyclin subunit imparts substrate specificity to the complex. Can also form CDK1-cylin-D and CDK1-cyclin-E complexes that phosphorylate RB1 in vitro. Binds to RB1 and other transcription factors such as FOXO1 and RUNX2. Promotes G2-M transition when in complex with a cyclin-B. Interacts with DLGAP5. Binds to the CDK inhibitors CDKN1A/p21 and CDKN1B/p27. Isoform 2 is unable to complex with cyclin-B1 and also fails to bind to CDKN1A/p21. Interacts with catalytically active CCNB1 and RALBP1 during mitosis to form an endocytotic complex during interphase. Associates with cyclins-A and B1 during S-phase in regenerating hepatocytes. Interacts with FANCC. Interacts with CEP63; this interaction recruits CDK1 to centrosomes.6 Publications

Binary interactionsi

WithEntry#Exp.IntActNotes
P030702EBI-444308,EBI-617698From a different organism.
BIRC5O153926EBI-444308,EBI-518823
CCNB1P146356EBI-444308,EBI-495332
CDC25CP303072EBI-444308,EBI-974439
EIF2AK2P195254EBI-444308,EBI-640775
FOXO1Q127785EBI-444308,EBI-1108782
LATS1O958352EBI-444308,EBI-444209
PKMYT1Q996403EBI-444308,EBI-495308
UBCP0CG486EBI-444308,EBI-3390054

Protein-protein interaction databases

BioGridi107420. 154 interactions.
DIPiDIP-35N.
IntActiP06493. 66 interactions.
MINTiMINT-5000894.
STRINGi9606.ENSP00000306043.

Structurei

Secondary structure

Legend: HelixTurnBeta strand
Show more details
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Beta strandi4 – 129
Beta strandi14 – 2310
Turni24 – 263
Beta strandi29 – 368
Beta strandi39 – 424
Helixi46 – 5712
Beta strandi66 – 716
Beta strandi73 – 819
Beta strandi84 – 863
Helixi87 – 937
Beta strandi94 – 963
Helixi102 – 12120
Beta strandi133 – 1364
Beta strandi142 – 1443
Helixi167 – 1693
Helixi172 – 1765
Helixi184 – 19916
Helixi209 – 22012
Turni225 – 2273
Beta strandi234 – 2363
Helixi249 – 2524
Turni253 – 2553
Helixi258 – 26710
Turni272 – 2743
Helixi278 – 2836
Helixi285 – 2873

3D structure databases

Select the link destinations:
PDBe
RCSB PDB
PDBj
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
1LC9model-A1-297[»]
ProteinModelPortaliP06493.
SMRiP06493. Positions 1-289.

Family & Domainsi

Domains and Repeats

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Domaini4 – 287284Protein kinase
Add
BLAST

Sequence similaritiesi

Phylogenomic databases

eggNOGiCOG0515.
HOVERGENiHBG014652.
KOiK02087.
OMAiGKMALKH.
PhylomeDBiP06493.
TreeFamiTF101021.

Family and domain databases

InterProiIPR011009. Kinase-like_dom.
IPR000719. Prot_kinase_dom.
IPR017441. Protein_kinase_ATP_BS.
IPR002290. Ser/Thr_dual-sp_kinase_dom.
IPR008271. Ser/Thr_kinase_AS.
[Graphical view]
PfamiPF00069. Pkinase. 1 hit.
[Graphical view]
SMARTiSM00220. S_TKc. 1 hit.
[Graphical view]
SUPFAMiSSF56112. SSF56112. 1 hit.
PROSITEiPS00107. PROTEIN_KINASE_ATP. 1 hit.
PS50011. PROTEIN_KINASE_DOM. 1 hit.
PS00108. PROTEIN_KINASE_ST. 1 hit.
[Graphical view]

Sequences (2)i

Sequence statusi: Complete.

This entry describes 2 isoformsi produced by alternative splicing. Align

Isoform 1 (identifier: P06493-1) [UniParc]FASTAAdd to Basket

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

« Hide

MEDYTKIEKI GEGTYGVVYK GRHKTTGQVV AMKKIRLESE EEGVPSTAIR    50
EISLLKELRH PNIVSLQDVL MQDSRLYLIF EFLSMDLKKY LDSIPPGQYM 100
DSSLVKSYLY QILQGIVFCH SRRVLHRDLK PQNLLIDDKG TIKLADFGLA 150
RAFGIPIRVY THEVVTLWYR SPEVLLGSAR YSTPVDIWSI GTIFAELATK 200
KPLFHGDSEI DQLFRIFRAL GTPNNEVWPE VESLQDYKNT FPKWKPGSLA 250
SHVKNLDENG LDLLSKMLIY DPAKRISGKM ALNHPYFNDL DNQIKKM 297
Length:297
Mass (Da):34,095
Last modified:May 31, 2011 - v3
Checksum:i942D79448EFE490A
GO
Isoform 2 (identifier: P06493-2) [UniParc]FASTAAdd to Basket

Also known as: CDC2deltaT

The sequence of this isoform differs from the canonical sequence as follows:
     107-163: Missing.

Show »
Length:240
Mass (Da):27,503
Checksum:i50FC3D192024E38C
GO

Sequence cautioni

The sequence EAW54204.1 differs from that shown. Reason: Erroneous gene model prediction.

Alternative sequence

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Alternative sequencei107 – 16357Missing in isoform 2.
VSP_021375Add
BLAST

Sequence databases

Select the link destinations:
EMBL
GenBank
DDBJ
Links Updated
X05360 mRNA. Translation: CAA28963.1.
Y00272 mRNA. Translation: CAA68376.1.
D88357 mRNA. Translation: BAA26001.1.
AK291939 mRNA. Translation: BAF84628.1.
BT007004 mRNA. Translation: AAP35650.1.
AF512554 Genomic DNA. Translation: AAM34793.1.
AC022390 Genomic DNA. No translation available.
CH471083 Genomic DNA. Translation: EAW54204.1. Sequence problems.
BC014563 mRNA. Translation: AAH14563.1.
CCDSiCCDS44408.1. [P06493-1]
CCDS7260.1. [P06493-2]
PIRiA29539.
RefSeqiNP_001777.1. NM_001786.4. [P06493-1]
NP_203698.1. NM_033379.4. [P06493-2]
XP_005270360.1. XM_005270303.1. [P06493-1]
XP_006718145.1. XM_006718082.1. [P06493-1]
XP_006718146.1. XM_006718083.1. [P06493-1]
UniGeneiHs.732435.

Genome annotation databases

EnsembliENST00000316629; ENSP00000325970; ENSG00000170312. [P06493-2]
ENST00000373809; ENSP00000362915; ENSG00000170312. [P06493-2]
ENST00000395284; ENSP00000378699; ENSG00000170312. [P06493-1]
GeneIDi983.
KEGGihsa:983.
UCSCiuc001jld.3. human. [P06493-1]
uc001jlg.3. human. [P06493-2]

Polymorphism databases

DMDMi334302921.

Keywords - Coding sequence diversityi

Alternative splicing

Cross-referencesi

Web resourcesi

NIEHS-SNPs

Sequence databases

Select the link destinations:
EMBL
GenBank
DDBJ
Links Updated
X05360 mRNA. Translation: CAA28963.1 .
Y00272 mRNA. Translation: CAA68376.1 .
D88357 mRNA. Translation: BAA26001.1 .
AK291939 mRNA. Translation: BAF84628.1 .
BT007004 mRNA. Translation: AAP35650.1 .
AF512554 Genomic DNA. Translation: AAM34793.1 .
AC022390 Genomic DNA. No translation available.
CH471083 Genomic DNA. Translation: EAW54204.1 . Sequence problems.
BC014563 mRNA. Translation: AAH14563.1 .
CCDSi CCDS44408.1. [P06493-1 ]
CCDS7260.1. [P06493-2 ]
PIRi A29539.
RefSeqi NP_001777.1. NM_001786.4. [P06493-1 ]
NP_203698.1. NM_033379.4. [P06493-2 ]
XP_005270360.1. XM_005270303.1. [P06493-1 ]
XP_006718145.1. XM_006718082.1. [P06493-1 ]
XP_006718146.1. XM_006718083.1. [P06493-1 ]
UniGenei Hs.732435.

3D structure databases

Select the link destinations:
PDBe
RCSB PDB
PDBj
Links Updated
Entry Method Resolution (Å) Chain Positions PDBsum
1LC9 model - A 1-297 [» ]
ProteinModelPortali P06493.
SMRi P06493. Positions 1-289.
ModBasei Search...
MobiDBi Search...

Protein-protein interaction databases

BioGridi 107420. 154 interactions.
DIPi DIP-35N.
IntActi P06493. 66 interactions.
MINTi MINT-5000894.
STRINGi 9606.ENSP00000306043.

Chemistry

BindingDBi P06493.
ChEMBLi CHEMBL308.
GuidetoPHARMACOLOGYi 1961.

PTM databases

PhosphoSitei P06493.

Polymorphism databases

DMDMi 334302921.

2D gel databases

SWISS-2DPAGE P06493.

Proteomic databases

MaxQBi P06493.
PaxDbi P06493.
PRIDEi P06493.

Protocols and materials databases

DNASUi 983.
Structural Biology Knowledgebase Search...

Genome annotation databases

Ensembli ENST00000316629 ; ENSP00000325970 ; ENSG00000170312 . [P06493-2 ]
ENST00000373809 ; ENSP00000362915 ; ENSG00000170312 . [P06493-2 ]
ENST00000395284 ; ENSP00000378699 ; ENSG00000170312 . [P06493-1 ]
GeneIDi 983.
KEGGi hsa:983.
UCSCi uc001jld.3. human. [P06493-1 ]
uc001jlg.3. human. [P06493-2 ]

Organism-specific databases

CTDi 983.
GeneCardsi GC10P062539.
HGNCi HGNC:1722. CDK1.
HPAi CAB003799.
HPA003387.
MIMi 116940. gene.
neXtProti NX_P06493.
PharmGKBi PA99.
GenAtlasi Search...

Phylogenomic databases

eggNOGi COG0515.
HOVERGENi HBG014652.
KOi K02087.
OMAi GKMALKH.
PhylomeDBi P06493.
TreeFami TF101021.

Enzyme and pathway databases

BRENDAi 2.7.11.22. 2681.
Reactomei REACT_1100. Golgi Cisternae Pericentriolar Stack Reorganization.
REACT_111214. G0 and Early G1.
REACT_1321. E2F-enabled inhibition of pre-replication complex formation.
REACT_1391. ERK1 activation.
REACT_150182. MASTL Facilitates Mitotic Progression.
REACT_150260. Condensation of Prometaphase Chromosomes.
REACT_150425. Resolution of Sister Chromatid Cohesion.
REACT_15296. Recruitment of mitotic centrosome proteins and complexes.
REACT_15364. Loss of Nlp from mitotic centrosomes.
REACT_15451. Loss of proteins required for interphase microtubule organization from the centrosome.
REACT_15510. Recruitment of NuMA to mitotic centrosomes.
REACT_160122. Activation of NIMA Kinases NEK9, NEK6, NEK7.
REACT_160315. Regulation of PLK1 Activity at G2/M Transition.
REACT_163931. Nuclear Pore Complex (NPC) Disassembly.
REACT_172744. Condensation of Prophase Chromosomes.
REACT_1846. G2/M DNA replication checkpoint.
REACT_1857. Cyclin A/B1 associated events during G2/M transition.
REACT_200828. Depolymerisation of the Nuclear Lamina.
REACT_2101. Cyclin B2 mediated events.
REACT_407. Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
REACT_471. E2F mediated regulation of DNA replication.
REACT_6362. Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes.
REACT_6820. APC/C:Cdc20 mediated degradation of Cyclin B.
REACT_683. G1/S-Specific Transcription.
REACT_6837. Regulation of APC/C activators between G1/S and early anaphase.
REACT_6875. Phosphorylation of Emi1.
REACT_6904. Phosphorylation of the APC/C.
SignaLinki P06493.

Miscellaneous databases

ChiTaRSi CDK1. human.
GeneWikii Cdk1.
Cyclin-dependent_kinase_1.
GenomeRNAii 983.
NextBioi 4122.
PROi P06493.
SOURCEi Search...

Gene expression databases

ArrayExpressi P06493.
Bgeei P06493.
CleanExi HS_CDC2.
Genevestigatori P06493.

Family and domain databases

InterProi IPR011009. Kinase-like_dom.
IPR000719. Prot_kinase_dom.
IPR017441. Protein_kinase_ATP_BS.
IPR002290. Ser/Thr_dual-sp_kinase_dom.
IPR008271. Ser/Thr_kinase_AS.
[Graphical view ]
Pfami PF00069. Pkinase. 1 hit.
[Graphical view ]
SMARTi SM00220. S_TKc. 1 hit.
[Graphical view ]
SUPFAMi SSF56112. SSF56112. 1 hit.
PROSITEi PS00107. PROTEIN_KINASE_ATP. 1 hit.
PS50011. PROTEIN_KINASE_DOM. 1 hit.
PS00108. PROTEIN_KINASE_ST. 1 hit.
[Graphical view ]
ProtoNeti Search...

Publicationsi

« Hide 'large scale' publications
  1. "Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2."
    Lee M.G., Nurse P.
    Nature 327:31-35(1987) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
  2. "T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21."
    Ohta T., Okamoto K., Isohashi F., Shibata K., Fukuda M., Yamaguchi S., Xiong Y.
    Cancer Res. 58:1095-1098(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
    Tissue: Mammary cancer.
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
  4. "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
    Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A.
    Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
  5. NIEHS SNPs program
    Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
  6. "The DNA sequence and comparative analysis of human chromosome 10."
    Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J.
    , Bird C.P., Ainscough R., Almeida J.P., Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.
    Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  7. Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  8. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
    Tissue: Skin.
  9. "Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement."
    Draetta G., Beach D.
    Cell 54:17-26(1988) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION, ASSOCIATION WITH P13.
  10. "Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15."
    Mueller P.R., Coleman T.R., Kumagai A., Dunphy W.G.
    Science 270:86-90(1995) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION AT THR-14 AND TYR-15 BY PKMYT1.
  11. "The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2."
    Kupfer G.M., Yamashita T., Naf D., Suliman A., Asano S., D'Andrea A.D.
    Blood 90:1047-1054(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH FANCC.
  12. "Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5."
    Meijer L., Borgne A., Mulner O., Chong J.P.J., Blow J.J., Inagaki N., Inagaki M., Delcros J.-G., Moulinoux J.-P.
    Eur. J. Biochem. 243:527-536(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: ENZYME REGULATION BY ROSCOVITINE AND OLOMOUCINE.
  13. "RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis."
    Rosse C., L'Hoste S., Offner N., Picard A., Camonis J.
    J. Biol. Chem. 278:30597-30604(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH RALBP1.
  14. "Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region."
    Hsu J.-M., Lee Y.-C.G., Yu C.-T.R., Huang C.-Y.F.
    J. Biol. Chem. 279:32592-32602(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH DLGAP5.
  15. "Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation."
    Qiao M., Shapiro P., Fosbrink M., Rus H., Kumar R., Passaniti A.
    J. Biol. Chem. 281:7118-7128(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS RUNX2 KINASE.
  16. "Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-dependent kinase Cdk1."
    Fourest-Lieuvin A., Peris L., Gache V., Garcia-Saez I., Juillan-Binard C., Lantez V., Job D.
    Mol. Biol. Cell 17:1041-1050(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS BETA-TUBULINS KINASE.
  17. "Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells."
    Westbrook L., Manuvakhova M., Kern F.G., Estes N.R. II, Ramanathan H.N., Thottassery J.V.
    Cancer Res. 67:11393-11401(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: INDUCTION BY CKS1B.
  18. "TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells."
    Hu X., Cui D., Moscinski L.C., Zhang X., Maccachero V., Zuckerman K.S.
    Cytokine 37:155-162(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS RB1 KINASE, ENZYME REGULATION BY TGFB1, REPRESSION BY TGFB1.
  19. "Microtubule deacetylases, SirT2 and HDAC6, in the nervous system."
    Southwood C.M., Peppi M., Dryden S., Tainsky M.A., Gow A.
    Neurochem. Res. 32:187-195(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS SIRT2 KINASE, SUBCELLULAR LOCATION.
  20. "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
    Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
    J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  21. "Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF."
    Pomerening J.R., Ubersax J.A., Ferrell J.E. Jr.
    Mol. Biol. Cell 19:3426-3441(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION DURING THE M PHASE, MUTAGENESIS OF 14-THR-TYR-15.
  22. "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
    Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
    Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-19; SER-39; TYR-77 AND THR-222, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  23. Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND TYR-15, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  24. "Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells."
    Tan F., Lu L., Cai Y., Wang J., Xie Y., Wang L., Gong Y., Xu B.-E., Wu J., Luo Y., Qiang B., Yuan J., Sun X., Peng X.
    Proteomics 8:2885-2896(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-89.
    Tissue: Cervix carcinoma.
  25. "Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons."
    Yuan Z., Becker E.B.E., Merlo P., Yamada T., DiBacco S., Konishi Y., Schaefer E.M., Bonni A.
    Science 319:1665-1668(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS FOXO1 KINASE, INTERACTION WITH FOXO1.
  26. "Sequential phosphorylation of Nedd1 by Cdk1 and Plk1 is required for targeting of the gammaTuRC to the centrosome."
    Zhang X., Chen Q., Feng J., Hou J., Yang F., Liu J., Jiang Q., Zhang C.
    J. Cell Sci. 122:2240-2251(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS NEDD1 KINASE.
  27. Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-19; SER-39; SER-178; THR-222 AND SER-248, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  28. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
    Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
    Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15 AND THR-161, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Leukemic T-cell.
  29. "Lysine acetylation targets protein complexes and co-regulates major cellular functions."
    Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M.
    Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND LYS-6, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  30. "Mitotic phosphorylation of Aki1 at Ser208 by cyclin B1-Cdk1 complex."
    Nakamura A., Naito M., Arai H., Fujita N.
    Biochem. Biophys. Res. Commun. 393:872-876(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS CC2D1A KINASE.
  31. "New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses."
    Yoon C.-H., Miah M.A., Kim K.P., Bae Y.-S.
    EMBO Rep. 11:393-399(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN G2 ARREST UPON DNA DAMAGE, PHOSPHORYLATION AT TYR-4 BY PKR/EIF2AK2, POLYUBIQUITINATION, MUTAGENESIS OF TYR-4.
  32. "The protein kinase Cdelta catalytic fragment is critical for maintenance of the G2/M DNA damage checkpoint."
    LaGory E.L., Sitailo L.A., Denning M.F.
    J. Biol. Chem. 285:1879-1887(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION AT TYR-15.
  33. "Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition."
    Timofeev O., Cizmecioglu O., Settele F., Kempf T., Hoffmann I.
    J. Biol. Chem. 285:16978-16990(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN G2-M TRANSITION, DEPHOSPHORYLATION AT THR-14 AND TYR-15 BY CDC25, PHOSPHORYLATION AT THR-161 BY CDK7/CAK, INTERACTION WITH B-CYCLIN.
  34. "Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis."
    Terrano D.T., Upreti M., Chambers T.C.
    Mol. Cell. Biol. 30:640-656(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS BCL-XL/BCL2L1 KINASE, SUBCELLULAR LOCATION.
  35. "Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity."
    Matthess Y., Raab M., Sanhaji M., Lavrik I.N., Strebhardt K.
    Mol. Cell. Biol. 30:5726-5740(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS CASP8 KINASE.
  36. "Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2."
    Chen S., Bohrer L.R., Rai A.N., Pan Y., Gan L., Zhou X., Bagchi A., Simon J.A., Huang H.
    Nat. Cell Biol. 12:1108-1114(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS EZH2 KINASE.
  37. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
    Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.
    Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  38. Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  39. "Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance."
    Loffler H., Fechter A., Matuszewska M., Saffrich R., Mistrik M., Marhold J., Hornung C., Westermann F., Bartek J., Kramer A.
    Cancer Res. 71:2129-2139(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH CEP63, SUBCELLULAR LOCATION.
  40. "CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore-microtubule attachment."
    Itoh G., Kanno S., Uchida K.S., Chiba S., Sugino S., Watanabe K., Mizuno K., Yasui A., Hirota T., Tanaka K.
    EMBO J. 30:130-144(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION AS CHAMP1 KINASE.
  41. Cited for: REVIEW ON SUBSTRATES, GENE FAMILY.
  42. "The decision to enter mitosis: feedback and redundancy in the mitotic entry network."
    Lindqvist A., Rodriguez-Bravo V., Medema R.H.
    J. Cell Biol. 185:193-202(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON SUBCELLULAR TRANSLOCATION.
  43. "Cell cycle, CDKs and cancer: a changing paradigm."
    Malumbres M., Barbacid M.
    Nat. Rev. Cancer 9:153-166(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON CELL CYCLE CONTROL AND INHIBITORS, GENE FAMILY.
  44. "Cdc2: a monopotent or pluripotent CDK?"
    Hu X., Moscinski L.C.
    Cell Prolif. 44:205-211(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON CELL CYCLE CONTROL.
  45. "Cyclin dependent kinase 1 inhibitors: a review of recent progress."
    Wang Q., Su L., Liu N., Zhang L., Xu W., Fang H.
    Curr. Med. Chem. 18:2025-2043(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON CELL CYCLE CONTROL AND INHIBITORS.
  46. "Checkpoint recovery in cells: how a molecular understanding can help in the fight against cancer."
    Medema R.H., Macurek L.
    F1000 Biol. Rep. 3:10-10(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: REVIEW ON CELL CYCLE CONTROL.
  47. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
    Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.
    Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  48. Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].

Entry informationi

Entry nameiCDK1_HUMAN
AccessioniPrimary (citable) accession number: P06493
Secondary accession number(s): A8K7C4, C9J497, O60764
Entry historyi
Integrated into UniProtKB/Swiss-Prot: January 1, 1988
Last sequence update: May 31, 2011
Last modified: September 3, 2014
This is version 191 of the entry and version 3 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Miscellaneous

As a key regulator of the cell cycle, CDK1 is a potent therapeutic target for inhibitors in cancer treatment (1 Publication).

Keywords - Technical termi

3D-structure, Complete proteome, Reference proteome

Documents

  1. Human chromosome 10
    Human chromosome 10: entries, gene names and cross-references to MIM
  2. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  3. PDB cross-references
    Index of Protein Data Bank (PDB) cross-references
  4. Human and mouse protein kinases
    Human and mouse protein kinases: classification and index
  5. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3

Similar proteinsi